Travis Alvin Thompson
CIK: 0001983944
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BICYCLE THERAPEUTICS PLC
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Oct 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct79 shares at avg. $3.57$282.03 - Oct 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct893 shares at avg. $3.47$3K - Jul 15, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)DirectEmployee Stock Option (right to buy)
60K shares- - Jul 6, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct104 shares at avg. $4.31$448.24 - Jul 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct819 shares at avg. $4.27$3K - Apr 6, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct102 shares at avg. $5.05$515.1 - Apr 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct799 shares at avg. $4.91$4K - Feb 3, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)DirectEmployee Stock Option (right to buy)
58K shares- - Jan 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.1K shares at avg. $6.45$7K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct37.5K shares- - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.3K shares at avg. $6.80$9K - Oct 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct103 shares at avg. $8.41$866.23 - Oct 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct221 shares at avg. $8.40$2K - Jul 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct100 shares at avg. $7.44$744 - Jul 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct206 shares at avg. $7.09$1K - Apr 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct109 shares at avg. $7.48$815.32 - Apr 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct210 shares at avg. $8.02$2K - Jan 6, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct2.7K shares at avg. $15.00$40K - Jan 3, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct159 shares at avg. $14.75$2K - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct17.5K shares- - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.8K shares at avg. $14.09$25K - Nov 11, 2024BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.1K shares at avg. $25.05$28K - Nov 11, 2024BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct3.2K shares at avg. $25.21$82K - Nov 11, 2024BCYC
BICYCLE THERAPEUTICS PLC
Exercise(M)Direct1.3K shares at avg. $1.87$2K - Nov 11, 2024BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct231 shares at avg. $24.82$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 79 | $3.57 | $282 | Direct |
| Oct 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 893 | $3.47 | $3,099 | Direct |
| Jul 15, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) Employee Stock Option (right to buy) | 60,000 | - | - | Direct |
| Jul 6, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 104 | $4.31 | $448 | Direct |
| Jul 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 819 | $4.27 | $3,497 | Direct |
| Apr 6, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 102 | $5.05 | $515 | Direct |
| Apr 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 799 | $4.91 | $3,923 | Direct |
| Feb 3, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) Employee Stock Option (right to buy) | 58,000 | - | - | Direct |
| Jan 5, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,115 | $6.45 | $7,192 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 37,500 | - | $0 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,317 | $6.80 | $8,956 | Direct |
| Oct 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 103 | $8.41 | $866 | Direct |
| Oct 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 221 | $8.40 | $1,856 | Direct |
| Jul 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 100 | $7.44 | $744 | Direct |
| Jul 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 206 | $7.09 | $1,461 | Direct |
| Apr 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 109 | $7.48 | $815 | Direct |
| Apr 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 210 | $8.02 | $1,684 | Direct |
| Jan 6, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 2,686 | $15.00 | $40,290 | Direct |
| Jan 3, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 159 | $14.75 | $2,345 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 17,500 | - | $0 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,750 | $14.09 | $24,658 | Direct |
| Nov 11, 2024 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,109 | $25.05 | $27,780 | Direct |
| Nov 11, 2024 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 3,241 | $25.21 | $81,706 | Direct |
| Nov 11, 2024 | BCYC BICYCLE THERAPEUTICS PLC | Exercise(M) | 1,312 | $1.87 | $2,453 | Direct |
| Nov 11, 2024 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 231 | $24.82 | $5,733 | Direct |
1-25 of 31 transactions
About Thompson Travis Alvin
Thompson Travis Alvin (SEC CIK 0001983944) files insider reports with the SEC as Chief Financial Officer of BICYCLE THERAPEUTICS PLC (BCYC).
Signal8 holds 13 ownership filings by Thompson Travis Alvin (1 Form 3, 12 Form 4), filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 31 transactions, from Oct 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Thompson Travis Alvin's filings is in CAMBRIDGE.
Recent filings by Thompson Travis Alvin
- Oct 5, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Oct 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Jul 15, 2026: Grant or award of BCYC derivative securities (Form 4, code A).
- Jul 6, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Jul 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)
- Perry Jennifer Scott, Chief Operating Officer
- Swanton Robert Charles, Director
- Skynner Michael, CHIEF SCIENTIFIC OFFICER
- Hannay Michael Charles Ferguson, CHIEF PROD & SUPPLY CHAIN OFF
- Lee Kevin, CHIEF EXECUTIVE OFFICER
- Milnes Alistair, CHIEF OPERATING OFFICER